YAP1 and hepatocellular carcinoma: In HCC, the knockdown of TAZ inhibits cell growth under normal conditions but induces compensatory upregulation of YAP1 together with an increase in the expression of the CSC marker CD90 in the presence of 5-FU, which contributes to chemoresistance [20].